Trials / Unknown
UnknownNCT02967094
Mucolytic Solution Before Upper Endoscopy
The Use of Mucolytic Solution Before Upper Endoscopy: A Randomized, Double-blinded Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Vitkovice Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study was designed to evaluate efficacy of mucolytic solution ingested before upper endoscopy on visibility of gastric mucosa.
Detailed description
Residual gastric content containing mucus, bubbles, bile and food particles may limit visibility of gastric mucosa and therefore diagnostic yield of upper endoscopy, especially in cases of early neoplastic lesions. Data on benefit of peroral mucolytic solution administered before upper endoscopy are limited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Administration of mucolytic solution before upper endoscopy (Espumisan, ACC long) | |
| DRUG | Administration of water before upper endoscopy |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-03-01
- Completion
- 2017-05-01
- First posted
- 2016-11-17
- Last updated
- 2016-11-29
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02967094. Inclusion in this directory is not an endorsement.